Rosell R - Search Results

1

Pemetrexed in previously treated non-small-cell lung cancer.

Rosell R, Sanchez JM, Taron M, Moran T, Ciuraqui B, Canela M, Felip E, Massuti B, Camps C. Rosell R, et al. Oncology (Williston Park). 2004 Jul;18(8 Suppl 5):63-71. Oncology (Williston Park). 2004. PMID: 15339062 Review.

2

Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer.

Rosell R, Carles J, Abad A, Jimeno JM, Moreno I, Barnadas A, Ribelles N, Haboubi N. Rosell R, et al. Invest New Drugs. 1992 Jul;10(2):123-8. doi: 10.1007/BF00873130. Invest New Drugs. 1992. PMID: 1323550 Clinical Trial.

3

Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancer.

Rosell R, Carles J, Abad A, Ribelles N, Barnadas A, Benavides A, Martin M. Rosell R, et al. Invest New Drugs. 1992 Aug;10(3):171-5. doi: 10.1007/BF00877242. Invest New Drugs. 1992. PMID: 1330970 Clinical Trial.

4

A phase II study of days 1 and 8 cisplatin and recombinant alpha-2B interferon in advanced non-small cell lung cancer.

Rosell R, Carles J, Ariza A, Moreno I, Ribelles N, Solano V, Pellicer I, Barnadas A, Abad A. Rosell R, et al. Cancer. 1991 May 15;67(10):2448-53. doi: 10.1002/1097-0142(19910515)67:10<2448::aid-cncr2820671009>3.0.co;2-2. Cancer. 1991. PMID: 1707745 Clinical Trial.

5

A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.

Rosell R, Abad-Esteve A, Moreno I, Barnadas A, Carles J, Fernandez C, Ribelles N, Culubret M. Rosell R, et al. Cancer. 1990 Apr 15;65(8):1692-9. doi: 10.1002/1097-0142(19900415)65:8<1692::aid-cncr2820650805>3.0.co;2-x. Cancer. 1990. PMID: 2156597 Review.

6

Cyclophosphamide and ifosfamide combination as neoadjuvant chemotherapy for locally advanced nonsmall-cell lung cancer: a meta-analytic review.

Rosell R, Moreno I, Maestre J, Olazabal A, Carles J, Barnadas A, Abad-Esteve A, Ribelles N, Canela M. Rosell R, et al. J Surg Oncol. 1990 Oct;45(2):124-30. doi: 10.1002/jso.2930450213. J Surg Oncol. 1990. PMID: 2170771

7

Quality of life during chemotherapy in non-small cell lung cancer patients.

Fernandez C, Rosell R, Abad-Esteve A, Monras P, Moreno I, Serichol M, Roviralta M. Fernandez C, et al. Among authors: rosell r. Acta Oncol. 1989;28(1):29-33. doi: 10.3109/02841868909111177. Acta Oncol. 1989. PMID: 2539845

8

Antiemetic efficacy of escalating doses of alizapride against chemotherapy-induced emesis.

Abad-Esteve A, Rosell R, Moreno I, Serichol M, Moya L, Ribas-Mundo M. Abad-Esteve A, et al. Among authors: rosell r. Oncology. 1989;46(4):235-7. doi: 10.1159/000226723. Oncology. 1989. PMID: 2740066

9

Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.

Carles J, Rosell R, Ariza A, Pellicer I, Sanchez JJ, Fernandez-Vasalo G, Abad A, Barnadas A. Carles J, et al. Among authors: rosell r. Lung Cancer. 1993 Dec;10(3-4):209-19. doi: 10.1016/0169-5002(93)90181-v. Lung Cancer. 1993. PMID: 7521264

10

Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer.

Rosell R, Molina F, Moreno I, Martínez E, Pifarré A, Font A, Li S, Skacel Z, Gómez-Codina J, Camps C, et al. Rosell R, et al. Lung Cancer. 1995 Apr;12 Suppl 1:S59-70. doi: 10.1016/0169-5002(95)00421-v. Lung Cancer. 1995. PMID: 7551935 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

839 results

Search Page

Filters